Literature DB >> 10337028

Expression of mucosa-related integrin alphaEbeta7 on alveolar T cells in interstitial lung diseases.

J Lohmeyer1, J Friedrich, F Grimminger, U Maus, R Tenter, H Morr, H G Velcovsky, W Seeger, S Rosseau.   

Abstract

The expression of alphaEbeta7 integrin has been related to the selective retention of lymphocytes in mucosal tissues of gut, urogenital tract and lung. To identify potential disease-associated alphaEbeta7 expression patterns on cells accounting for lymphocytic alveolitis in interstitial lung disease (ILD), alphaE expression on CD4+ and CD8+ T cell subsets was evaluated by dual-colour flow cytometry in peripheral blood and bronchoalveolar lavage fluid (BALF) of patients with idiopathic pulmonary fibrosis (IPF; n = 18), hypersensitivity pneumonitis (HP; n = 20) and sarcoidosis (n = 44) in comparison with healthy controls (n = 15). In both healthy individuals and all patient groups the proportion of alphaE-bearing T cells in peripheral blood was < 2%, whereas the vast majority of alveolar CD8+ T cells consistently co-expressed alphaE. Absolute alveolar CD8+alphaE+ cell numbers/ml were up to 30-fold increased in HP patients. Proportions of alphaE-bearing CD4+ cells in BALF were significantly elevated in IPF (74.0 +/- 2.7%) and HP (70.0 +/- 2.4%) compared with normals (30.0 +/- 1.8%) (mean +/- s.e.m.; P < 0.01). In sarcoidosis, the alphaE expression on BALF CD4+ cells displayed subgroup dependency: proportions significantly lower than normal were noted in chest radiographic stage I (14.3 +/- 1.5%), but increased proportions in stages II (50.0 +/- 3.8%) and III (64.0 +/- 4.8%). Correlations between common markers of T cell activation or BALF transforming growth factor-beta (TGF-beta ) bioactivity and alphaE expression were not noted. We conclude that the vast majority of alveolar CD8+ T cells consistently express alphaEbeta7 and that distinct patterns of alphaEbeta7 expression on alveolar CD4+ lymphocytes in sarcoidosis are related to the diverse manifestations of the sarcoid inflammatory process in the lung.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10337028      PMCID: PMC1905287          DOI: 10.1046/j.1365-2249.1999.00894.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  27 in total

1.  A new surface antigen on intraepithelial lymphocytes in the intestine.

Authors:  P J Kilshaw; S J Murant
Journal:  Eur J Immunol       Date:  1990-10       Impact factor: 5.532

Review 2.  Sarcoidosis.

Authors:  L S Newman; C S Rose; L A Maier
Journal:  N Engl J Med       Date:  1997-04-24       Impact factor: 91.245

3.  A unique surface antigen on intraepithelial lymphocytes in the mouse.

Authors:  P J Kilshaw; K C Baker
Journal:  Immunol Lett       Date:  1988-06       Impact factor: 3.685

4.  High levels of transforming growth factor-beta are present in the epithelial lining fluid of the normal human lower respiratory tract.

Authors:  K Yamauchi; Y Martinet; P Basset; G A Fells; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1988-06

5.  A monoclonal antibody (HML-1) defining a novel membrane molecule present on human intestinal lymphocytes.

Authors:  N Cerf-Bensussan; A Jarry; N Brousse; B Lisowska-Grospierre; D Guy-Grand; C Griscelli
Journal:  Eur J Immunol       Date:  1987-09       Impact factor: 5.532

6.  Differential expression of alpha E beta 7 integrins on bronchoalveolar lavage T lymphocyte subsets: regulation by alpha 4 beta 1-integrin crosslinking and TGF-beta.

Authors:  S Rihs; C Walker; J C Virchow; C Boer; C Kroegel; S N Giri; R K Braun
Journal:  Am J Respir Cell Mol Biol       Date:  1996-11       Impact factor: 6.914

7.  Anti-inflammatory cytokine release by alveolar macrophages in pulmonary sarcoidosis.

Authors:  G Zissel; J Homolka; J Schlaak; M Schlaak; J Müller-Quernheim
Journal:  Am J Respir Crit Care Med       Date:  1996-09       Impact factor: 21.405

8.  Transforming growth factor-beta 1-induced expression of the mucosa-related integrin alpha E on lymphocytes is not associated with mucosa-specific homing.

Authors:  F Austrup; S Rebstock; P J Kilshaw; A Hamann
Journal:  Eur J Immunol       Date:  1995-06       Impact factor: 5.532

9.  Human transforming growth factor type beta 2: production by a prostatic adenocarcinoma cell line, purification, and initial characterization.

Authors:  T Ikeda; M N Lioubin; H Marquardt
Journal:  Biochemistry       Date:  1987-05-05       Impact factor: 3.162

10.  Increased production and immunohistochemical localization of transforming growth factor-beta in idiopathic pulmonary fibrosis.

Authors:  N Khalil; R N O'Connor; H W Unruh; P W Warren; K C Flanders; A Kemp; O H Bereznay; A H Greenberg
Journal:  Am J Respir Cell Mol Biol       Date:  1991-08       Impact factor: 6.914

View more
  11 in total

1.  A humanized monoclonal antibody targeting the β7 integrin selectively blocks intestinal homing of T lymphocytes.

Authors:  E G Stefanich; D M Danilenko; H Wang; S O'Byrne; R Erickson; T Gelzleichter; H Hiraragi; H Chiu; S Ivelja; S Jeet; S Gadkari; O Hwang; F Fuh; C Looney; K Howell; V Albert; M Balazs; C Refino; S Fong; S Iyer; M Williams
Journal:  Br J Pharmacol       Date:  2011-04       Impact factor: 8.739

Review 2.  Takes your breath away--the immunology of allergic alveolitis.

Authors:  C McSharry; K Anderson; S J Bourke; G Boyd
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

3.  alphaEbeta7 expression on CD8+ T-cells in COPD BAL fluid and on TGF-beta stimulated T-cells in vitro.

Authors:  Pernilla S Glader; Claes-Göran A Löfdahl; Karin A von Wachenfeldt
Journal:  Lung       Date:  2005 Mar-Apr       Impact factor: 2.584

4.  Human bronchial intraepithelial T cells produce interferon-gamma and stimulate epithelial cells.

Authors:  S Hirosako; E Goto; K Fujii; K Tsumori; N Hirata; S Tsumura; H Kamohara; H Kohrogi
Journal:  Clin Exp Immunol       Date:  2008-11-26       Impact factor: 4.330

5.  Integrin α E β 7 (CD103) expression in bronchoalveolar lymphocytes of patients with hypersensitivity pneumonitis.

Authors:  Mariana Couto; Carmo Palmares; Marília Beltrão; Sofia Neves; Patrícia Mota; António Morais; Luís Delgado
Journal:  Int Arch Occup Environ Health       Date:  2014-05-30       Impact factor: 3.015

6.  Evaluation of recombinant influenza virus-simian immunodeficiency virus vaccines in macaques.

Authors:  Amy Sexton; Robert De Rose; Jeanette C Reece; Sheilajen Alcantara; Liyen Loh; Jessica M Moffat; Karen Laurie; Aeron Hurt; Peter C Doherty; Stephen J Turner; Stephen J Kent; John Stambas
Journal:  J Virol       Date:  2009-05-13       Impact factor: 5.103

7.  BAL biomarkers' panel for differential diagnosis of interstitial lung diseases.

Authors:  Miriana d'Alessandro; Alfonso Carleo; Paolo Cameli; Laura Bergantini; Anna Perrone; Lucia Vietri; Nicola Lanzarone; Cecilia Vagaggini; Piersante Sestini; Elena Bargagli
Journal:  Clin Exp Med       Date:  2020-01-22       Impact factor: 3.984

8.  T-cell activation profiles in different granulomatous interstitial lung diseases--a role for CD8+CD28(null) cells?

Authors:  M Heron; A M E Claessen; J C Grutters; J M M van den Bosch
Journal:  Clin Exp Immunol       Date:  2009-12-17       Impact factor: 4.330

Review 9.  Integrins as Therapeutic Targets for Respiratory Diseases.

Authors:  C M Teoh; S S L Tan; T Tran
Journal:  Curr Mol Med       Date:  2015       Impact factor: 2.222

10.  Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration.

Authors:  Reinhold Schmidt; Philipp Markart; Clemens Ruppert; Malgorzata Wygrecka; Tim Kuchenbuch; Dieter Walmrath; Werner Seeger; Andreas Guenther
Journal:  Respir Res       Date:  2007-07-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.